{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:50:35Z","timestamp":1791089435129,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"crossref"}]},{"name":"EU\/EFPIA Innovative Medicines Initiative"},{"name":"AMYPAD"},{"name":"EUJU"},{"name":"National Institute for Health and Care Research - Biomedical Research Center"},{"name":"General Eletronic (GE) HealthCare"},{"name":"Alzheimer\u2019s Disease Data Initiative"},{"name":"ADDI"},{"name":"JPND Neurodegenerative Disease Research"},{"name":"Medical Research Council, United Kingdom"},{"name":"ZonMW, Netherlands"},{"name":"Nationale de la Recherche, France"},{"name":"Italian Ministry of Health (MoH), Italy"},{"name":"National Health & Medical Research Council, Australia"},{"name":"National Research, Development and Innovation Office, Hungary"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Exploring the early stages of Alzheimer's disease (AD) is crucial for timely intervention to help manage symptoms and set expectations for affected individuals and their families. However, the study of the early stages of AD involves analysing heterogeneous disease cohorts which may present challenges for some modelling techniques. This heterogeneity stems from the diverse nature of AD itself, as well as the inclusion of undiagnosed or \u2018at-risk\u2019 AD individuals or the presence of comorbidities which differentially affect AD biomarkers within the cohort. Normative modelling is an emerging technique for studying heterogeneous disorders that can quantify how brain imaging-based measures of individuals deviate from a healthy population. The normative model provides a statistical description of the \u2018normal\u2019 range that can be used at subject level to detect deviations, which may relate to pathological effects.\n<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this work, we applied a deep learning-based normative model, pre-trained on MRI scans in the UK Biobank, to investigate ageing and identify abnormal age-related decline. We calculated deviations, relative to the healthy population, in multi-modal MRI data of non-demented individuals in the external EPAD (ep-ad.org) cohort and explored these deviations with the aim of determining whether normative modelling could detect AD-relevant subtle differences between individuals.\n<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We found that aggregate measures of deviation based on the entire brain correlated with measures of cognitive ability and biological phenotypes, indicating the effectiveness of a general deviation metric in identifying AD-related differences among individuals. We then explored deviations in individual imaging features, stratified by cognitive performance and genetic risk, across different brain regions and found that the brain regions showing deviations corresponded to those affected by AD such as the hippocampus. Finally, we found that \u2018at-risk\u2019 individuals in the EPAD cohort exhibited increasing deviation over time, with an approximately 6.4 times greater t-statistic in a pairwise t-test compared to a \u2018super-healthy\u2019 cohort.\n<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study highlights the capability of deep normative modelling approaches to detect subtle differences in brain morphology among individuals at risk of developing AD in a non-demented population. Our findings allude to the potential utility of normative deviation metrics in monitoring disease progression.\n<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13195-025-01753-3","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T07:27:19Z","timestamp":1747294039000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Deep normative modelling reveals insights into early-stage Alzheimer's disease using multi-modal neuroimaging data"],"prefix":"10.1186","volume":"17","author":[{"given":"Ana","family":"Lawry Aguila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Lorenzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Janahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Barkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Altmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"key":"1753_CR1","unstructured":"WHO. Dementia. 2023. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia."},{"key":"1753_CR2","first-page":"11","volume":"22","author":"JE Galvin","year":"2021","unstructured":"Galvin JE, Aisen P, Langbaum JB, Rodriguez E, Sabbagh M, Stefanacci R, et al. Early stages of Alzheimer\u2019s disease: evolving the care team for optimal patient management. Front Neurol. 2021;22:11.","journal-title":"Front Neurol"},{"key":"1753_CR3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet. 2020;396:413\u201346 Lancet Publishing Group.","journal-title":"The Lancet"},{"key":"1753_CR4","first-page":"629","volume":"10","author":"D Goyal","year":"2018","unstructured":"Goyal D, Tjandra D, Migrino RQ, Giordani B, Syed Z, Wiens J. Characterizing heterogeneity in the progression of Alzheimer\u2019s disease using longitudinal clinical and neuroimaging biomarkers. Alzheimer\u2019s and Dementia: Diagnosis, Assessment and Disease Monitoring. 2018;10:629\u201337.","journal-title":"Alzheimer\u2019s and Dementia: Diagnosis, Assessment and Disease Monitoring"},{"issue":"3","key":"1753_CR5","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3233\/JAD-210144","volume":"81","author":"M Pais","year":"2021","unstructured":"Pais M, Loureiro J, Do Vale V, Radanovic M, Talib L, Stella F, et al. Heterogeneity of cerebrospinal fluid biomarkers profiles in individuals with distinct levels of cognitive decline: a cross-sectional study. Journal of Alzheimer\u2019s Disease. 2021;81(3):949\u201362.","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"1","key":"1753_CR6","doi-asserted-by":"publisher","first-page":"e14408","DOI":"10.15252\/emmm.202114408","volume":"14","author":"A Leuzy","year":"2022","unstructured":"Leuzy A, Mattsson-Carlgren N, Palmqvist S, Janelidze S, Dage JL, Hansson O. Blood-based biomarkers for Alzheimer\u2019s disease. EMBO Mol Med. 2022;14(1):e14408.","journal-title":"EMBO Mol Med"},{"key":"1753_CR7","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S1474-4422(20)30314-8","volume":"19","author":"G Ch\u00e9telat","year":"2020","unstructured":"Ch\u00e9telat G, Arbizu J, Barthel H, Garibotto V, Law I, Morbelli S, et al. Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer\u2019s disease and other dementias. The Lancet Neurology. 2020;19:951\u201362 Lancet Publishing Group.","journal-title":"The Lancet Neurology"},{"key":"1753_CR8","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S1474-4422(22)00168-5","volume":"12","author":"R Ossenkoppele","year":"2022","unstructured":"Ossenkoppele R, van der Kant R, Hansson O. Tau biomarkers in Alzheimer\u2019s disease: towards implementation in clinical practice and trials. The Lancet Neurology. 2022;12:726\u201334 Elsevier Ltd.","journal-title":"The Lancet Neurology"},{"key":"1753_CR9","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s11910-014-0499-8","volume":"14","author":"JM Ringman","year":"2014","unstructured":"Ringman JM, Goate A, Masters CL, Cairns NJ, Danek A, Graff-Radford N, et al. Genetic heterogeneity in Alzheimer disease and implications for treatment strategies. Curr Neurol Neurosci Rep. 2014;14:499 Current Medicine Group LLC 1.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"1753_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13195-021-00785-9","volume":"13","author":"F Levin","year":"2021","unstructured":"Levin F, Ferreira D, Lange C, Dyrba M, Westman E, Buchert R, et al. Data-driven FDG-PET subtypes of Alzheimer\u2019s disease-related neurodegeneration. Alzheimers Res Ther. 2021;13(1):49.","journal-title":"Alzheimers Res Ther"},{"key":"1753_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13024-019-0325-5","volume":"14","author":"F M\u00e1rquez","year":"2019","unstructured":"M\u00e1rquez F, Yassa MA. Neuroimaging biomarkers for Alzheimer\u2019s disease. Molecular Neurodegeneration. 2019;14:21 BioMed Central Ltd.","journal-title":"Molecular Neurodegeneration"},{"issue":"6","key":"1753_CR12","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1088\/1361-6560\/aa5dbe","volume":"62","author":"T Maggipinto","year":"2017","unstructured":"Maggipinto T, Bellotti R, Amoroso N, Diacono D, Donvito G, Lella E, et al. DTI measurements for Alzheimer\u2019s classification. Phys Med Biol. 2017;62(6):2361\u201375.","journal-title":"Phys Med Biol"},{"issue":"6","key":"1753_CR13","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1002\/acn3.52071","volume":"11","author":"M Tranfa","year":"2024","unstructured":"Tranfa M, Lorenzini L, Collij LE, V\u00e1llez Garc\u00eda D, Ingala S, Pontillo G, et al. Alzheimer\u2019s disease and small vessel disease differentially affect white matter microstructure. Ann Clin Transl Neurol. 2024;11(6):1541\u201356.","journal-title":"Ann Clin Transl Neurol"},{"key":"1753_CR14","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.nicl.2013.07.006","volume":"3","author":"TM Nir","year":"2013","unstructured":"Nir TM, Jahanshad N, Villalon-Reina JE, Toga AW, Jack CR, Weiner MW, et al. Effectiveness of regional DTI measures in distinguishing Alzheimer\u2019s disease, MCI, and normal aging. Neuroimage Clin. 2013;3:180\u201395.","journal-title":"Neuroimage Clin"},{"key":"1753_CR15","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1093\/brain\/awy264","volume":"141","author":"M ten Kate","year":"2018","unstructured":"ten Kate M, Dicks E, Jelle Visser P, van der Flier WM, Teunissen CE, Barkhof F, et al. Atrophy subtypes in prodromal Alzheimer\u2019s disease are associated with cognitive decline. Brain. 2018;141:3280\u20139 Oxford University Press.","journal-title":"Brain"},{"issue":"1","key":"1753_CR16","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1038\/s41467-018-05892-0","volume":"9","author":"AL Young","year":"2018","unstructured":"Young AL, Marinescu RV, Oxtoby NP, Bocchetta M, Yong K, Firth NC, et al. Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with subtype and stage inference. Nat Commun. 2018;9(1):4273.","journal-title":"Nat Commun"},{"key":"1753_CR17","first-page":"85082","volume":"12","author":"S Rutherford","year":"2023","unstructured":"Rutherford S, Barkema P, Tso IF, Sripada C, Beckmann CF, Ruhe HG, et al. Evidence for embracing normative modeling. 2023;12:85082.","journal-title":"Evidence for embracing normative modeling"},{"key":"1753_CR18","doi-asserted-by":"crossref","unstructured":"Janahi M, Aksman L, Schott JM, Mokrab Y, Altmann A. Nomograms of human hippocampal volume shifted by polygenic scores. Elife. 2022;11:e78232.","DOI":"10.7554\/eLife.78232"},{"key":"1753_CR19","doi-asserted-by":"crossref","unstructured":"Lawry Aguila A, Chapman J, Altmann A. Multi-modal variational autoencoders for normative modelling across multiple imaging modalities. 2023. Available from: http:\/\/arxiv.org\/abs\/2303.12706.","DOI":"10.1007\/978-3-031-43907-0_41"},{"key":"1753_CR20","unstructured":"Kumar S, Payne P, Sotiras A. Normative modeling using multimodal variational autoencoders to identify abnormal brain structural patterns in Alzheimer disease. 2021. Available from: http:\/\/arxiv.org\/abs\/2110.04903."},{"key":"1753_CR21","doi-asserted-by":"crossref","unstructured":"Lawry Aguila A, Chapman J, Janahi M, Altmann A. Conditional VAEs for confound removal and normative modelling of neurodegenerative diseases. In: Medical Image Computing and Computer Assisted Intervention \u2013 MICCAI 2022: 25th International Conference. 2022. p. 430\u201340.","DOI":"10.1007\/978-3-031-16431-6_41"},{"key":"1753_CR22","unstructured":"Lawry Aguila A, Altmann A. A tutorial on multi-view autoencoders using the multi-view-AE library. 2024. Available from: http:\/\/arxiv.org\/abs\/2403.07456."},{"key":"1753_CR23","doi-asserted-by":"crossref","unstructured":"Lee M, Pavlovic V. Private-shared disentangled multimodal VAE for learning of latent representations. In: 2021 IEEE\/CVF Conference on Computer Vision and Pattern Recognition Workshops (CVPRW). 2021.","DOI":"10.1109\/CVPRW53098.2021.00185"},{"issue":"12","key":"1753_CR24","doi-asserted-by":"publisher","first-page":"e021017","DOI":"10.1136\/bmjopen-2017-021017","volume":"8","author":"A Solomon","year":"2018","unstructured":"Solomon A, Kivipelto M, Molinuevo JL, Tom B, Ritchie CW. European Prevention of Alzheimer\u2019s Dementia Longitudinal Cohort Study (EPAD LCS): study protocol. BMJ Open. 2018;8(12):e021017.","journal-title":"BMJ Open"},{"key":"1753_CR25","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.neuroimage.2017.10.034","volume":"166","author":"F Alfaro-Almagro","year":"2018","unstructured":"Alfaro-Almagro F, Jenkinson M, Bangerter NK, Andersson JLR, Griffanti L, Douaud G, et al. Image processing and quality control for the first 10,000 brain imaging datasets from UK Biobank. Neuroimage. 2018;166:400\u201324.","journal-title":"Neuroimage"},{"key":"1753_CR26","doi-asserted-by":"crossref","unstructured":"Khan TK. Clinical diagnosis of Alzheimer\u2019s disease. In: Biomarkers in Alzheimer\u2019s disease.\u00a0Biomarkers in Alzheimer's Disease: Elsevier. 2016. p. 27\u201348.","DOI":"10.1016\/B978-0-12-804832-0.00002-X"},{"key":"1753_CR27","doi-asserted-by":"crossref","unstructured":"Perneczky R, Wagenpfeil S, Komossa K, Diehl J, Kurz A. Mapping scores onto stages: mini-mental state examination and clinical dementia rating. 2006.","DOI":"10.1097\/01.JGP.0000192478.82189.a8"},{"key":"1753_CR28","doi-asserted-by":"publisher","first-page":"103106","DOI":"10.1016\/j.nicl.2022.103106","volume":"35","author":"L Lorenzini","year":"2022","unstructured":"Lorenzini L, Ingala S, Wink AM, Kuijer JPA, Wottschel V, Dijsselhof M, et al. The Open-Access European Prevention of Alzheimer\u2019s Dementia (EPAD) MRI dataset and processing workflow. Neuroimage Clin. 2022;35:103106.","journal-title":"Neuroimage Clin"},{"issue":"7","key":"1753_CR29","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1002\/alz.12292","volume":"17","author":"S Ingala","year":"2021","unstructured":"Ingala S, De Boer C, Masselink LA, Vergari I, Lorenzini L, Blennow K, et al. Application of the ATN classification scheme in a population without dementia: findings from the EPAD cohort. Alzheimer\u2019s and Dementia. 2021;17(7):1189\u2013204.","journal-title":"Alzheimer\u2019s and Dementia"},{"key":"1753_CR30","doi-asserted-by":"publisher","first-page":"116450","DOI":"10.1016\/j.neuroimage.2019.116450","volume":"208","author":"R Pomponio","year":"2020","unstructured":"Pomponio R, Erus G, Habes M, Doshi J, Srinivasan D, Mamourian E, et al. Harmonization of large MRI datasets for the analysis of brain imaging patterns throughout the lifespan. Neuroimage. 2020;208:116450.","journal-title":"Neuroimage"},{"issue":"85","key":"1753_CR31","doi-asserted-by":"publisher","first-page":"5093","DOI":"10.21105\/joss.05093","volume":"8","author":"A Lawry Aguila","year":"2023","unstructured":"Lawry Aguila A, Jayme A, Monta\u00f1a-Brown N, Heuveline V, Altmann A. Multi-view-AE: a python package for multi-view autoencoder models. J Open Source Softw. 2023;8(85):5093.","journal-title":"J Open Source Softw"},{"issue":"1","key":"1753_CR32","doi-asserted-by":"publisher","first-page":"15746","DOI":"10.1038\/s41598-021-95098-0","volume":"11","author":"WHL Pinaya","year":"2021","unstructured":"Pinaya WHL, Scarpazza C, Garcia-Dias R, Vieira S, Baecker L, da Costa PF, et al. Using normative modelling to detect disease progression in mild cognitive impairment and Alzheimer\u2019s disease in a cross-sectional multi-cohort study. Sci Rep. 2021;11(1):15746.","journal-title":"Sci Rep"},{"key":"1753_CR33","first-page":"897","volume":"14","author":"MJ De Leon","year":"1993","unstructured":"De Leon MJ, Golomb J, George AE, Convit A, Tarshish CY, Mcrae T, et al. The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. American Journal of Neuroradiology. 1993;14:897\u2013906.","journal-title":"American Journal of Neuroradiology"},{"issue":"9","key":"1753_CR34","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1038\/s41593-023-01404-6","volume":"26","author":"A Segal","year":"2023","unstructured":"Segal A, Parkes L, Aquino K, Kia SM, Wolfers T, Franke B, et al. Regional, circuit and network heterogeneity of brain abnormalities in psychiatric disorders. Nat Neurosci. 2023;26(9):1613\u201329.","journal-title":"Nat Neurosci"},{"issue":"3","key":"1753_CR35","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1152\/jn.00338.2011","volume":"106","author":"BT Thomas Yeo","year":"2011","unstructured":"Thomas Yeo BT, Krienen FM, Sepulcre J, Sabuncu MR, Lashkari D, Hollinshead M, et al. The organization of the human cerebral cortex estimated by intrinsic functional connectivity. J Neurophysiol. 2011;106(3):1125\u201365.","journal-title":"J Neurophysiol"},{"key":"1753_CR36","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple. Journal of the Royal Statistical Society Series B (Methodological). 1995;57:289.","journal-title":"Journal of the Royal Statistical Society Series B (Methodological)"},{"issue":"24","key":"1753_CR37","doi-asserted-by":"publisher","first-page":"E2442","DOI":"10.1212\/WNL.0000000000207298","volume":"100","author":"S Verdi","year":"2023","unstructured":"Verdi S, Kia SM, Yong KXX, Tosun D, Schott JM, Marquand AF, et al. Revealing individual neuroanatomical heterogeneity in Alzheimer disease using neuroanatomical normative modeling. Neurology. 2023;100(24):E2442\u201353.","journal-title":"Neurology"},{"key":"1753_CR38","first-page":"1","volume":"85","author":"MW Hooper","year":"1976","unstructured":"Hooper MW, Vogel FS. The limbic system in Alzheimer\u2019s Disease A Neuropathologic Investigation. Am J Pathol October. 1976;85:1.","journal-title":"Am J Pathol October"},{"key":"1753_CR39","doi-asserted-by":"crossref","unstructured":"Petersen RC, Aisen PS, Beckett LA, Donohue MC, Gamst AC, Harvey DJ, et al. Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) clinical characterization. 2010. Available from: https:\/\/www.neurology.org\/.","DOI":"10.1212\/WNL.0b013e3181cb3e25"},{"key":"1753_CR40","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.neuroimage.2017.11.024","volume":"167","author":"JP Fortin","year":"2018","unstructured":"Fortin JP, Cullen N, Sheline YI, Taylor WD, Aselcioglu I, Cook PA, et al. Harmonization of cortical thickness measurements across scanners and sites. Neuroimage. 2018;167:104\u201320.","journal-title":"Neuroimage"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01753-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01753-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01753-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T07:27:25Z","timestamp":1747294045000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01753-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1753"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01753-3","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"assertion":[{"value":"8 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}